The global neurogenomics market is projected to grow from $1.59 billion in 2024 to $4.68 billion by 2031, at a CAGR of 16.6%. Key growth drivers include declining sequencing costs, rising neurological disorder prevalence, and advancements in sequencing technologies. https://www.meticulousresearch.com/product/neurogenomics-market-6019